NEVVI Medicare utilization intelligence
+ Build a code basket
Market snapshot

Nationwide CY2024

Medicare Part B FFS · CY2024 · as published by CMS
81206 Translocation analysis (bcr/abl1) major breakpoint CPT · Molecular Testing
Classification Test Molecular Testing Genetic Analysis (CMS RBCS)
First observed 2013 — start of our 12-year window; the code predates it
National scale 26,073 services ▲ 5.1% YoY · 12,327 beneficiaries (CY2024, Medicare FFS)
Medicare paid $4.2M · $160.03 avg / service, national
CMS descriptor · RBCS classification · Medicare Part B physician/supplier claims, 12-year window
Billing groups
4
Named-group FFS services
2,624
FFS of Medicare
49%
Services YoY
+5.1%
FFS enrollment -2.2%
Estimated all-Medicare volume FFS + estimated MA estimate
~5,952 services

2,624 observed fee-for-service (44%) · ~3,328 estimated Medicare Advantage. Scaled from the observed floor by each state’s fee-for-service share (FFS share as of 2024) — scaled estimate — assumes MA utilization mirrors FFS; not an observation. How we scale

Top states — 81206 (CY2024)

Disclosed Medicare fee-for-service services by billing state; open a bar for that state's ranked market.

Named-group submitted charges
$1.1M
Named-group allowed amount
$421K
Named-group Medicare payments
$421K
Avg charge / svc
$419
Avg allowed / svc
$160
Avg payment / svc
$160
Average charge per group
$283 4 groups · avg submitted charge / service $600
Market analyticsPlatform
a taste of the twelve-year trend layer

Or just look at it: nuclear heart imaging (78452) in Arizona is open as a live example — the full paid view, real data.

View the live example →

Nevvi's market analytics platform — code baskets, market structure and share, the twelve-year trend layer — is built and not launched yet. We're gathering interest in it.

Notify me at launch →
Refine: practice size any 5+ 25+ 100+ independent only
Filter results:

Email me this CSV

Data year: CY2024 CY2023 CY2022 locked column CY2021 locked column CY2020 locked column
Physician groups ranked by 81206 services, highest first, CY2024
# Physician group activate to sort City activate to sort St activate to sort Specialty activate to sort Providers activate to sort 81206 svcs sorted descending — activate to reverse Submitted charges activate to sort Avg charge activate to sort Medicare $ locked column Share* activate to sort Phone
1 FLORIDA CANCER SPECIALISTS AND RESEARCH INSTITUTE, LLC FORT MYERS FL HEMATOLOGY/ONCOLOGY 437 1,650 $704,550 $427 premium 23.4% (239) 561-9622
2 TENNESSEE ONCOLOGY PLLC NASHVILLE TN HEMATOLOGY/ONCOLOGY 360 457 $129,198 $283 premium 63.2% (615) 385-3751
3 ONCOLOGY SPECIALTIES, P.C. HUNTSVILLE AL NURSE PRACTITIONER 93 282 $169,200 $600 premium 100.0% (256) 705-4224
4 AMERICAN ONCOLOGY PARTNERS PA FORT WAYNE FL HEMATOLOGY/ONCOLOGY 333 235 $96,350 $410 premium 3.3% (260) 484-8830

*Share of the state's disclosed Medicare-FFS services for the primary code, counted once per clinician. "St" is the state the volume was billed from: a group appears in each state where its clinicians bill Medicare, with that state's volume and share ("City" is the group's registered location). Group figures sum clinicians affiliated with exactly one group; clinicians in several groups are listed in each group's drill-down but not volume-attributed to any single group, so shares reflect attributable volume. See Methods.

Comparing against an all-payer estimate?

These are exact counts from Medicare fee-for-service claims — roughly a third to half of most procedure markets, depending on payer mix. Modeled all-payer databases project the remainder statistically; we publish the audited floor and label it as such. Same market, different denominator. How the numbers reconcile →